A phytosphingosine derivative mYG-II-6 inhibits histamine-mediated TRPV1 activation and MRGPRX2-dependent mast cell degranulation

Int Immunopharmacol. 2024 May 30:133:112113. doi: 10.1016/j.intimp.2024.112113. Epub 2024 Apr 23.

Abstract

Background: Phytosphingosine and its derivative are known for their skin-protective properties. While mYG-II-6, a phytosphingosine derivative, has shown anti-inflammatory and antipsoriatic effects, its potential antipruritic qualities have yet to be explored. This study aimed to investigate mYG-II-6's antipruritic properties.

Methods: The calcium imaging technique was employed to investigate the activity of ion channels and receptors. Mast cell degranulation was confirmed through the β-hexosaminidase assay. Additionally, in silico molecular docking and an in vivo mouse scratching behavior test were utilized.

Results: Using HEK293T cells transfected with H1R and TRPV1, we examined the impact of mYG-II-6 on histamine-induced intracellular calcium rise, a key signal in itch-mediating sensory neurons. Pretreatment with mYG-II-6 significantly reduced histamine-induced calcium levels and inhibited TRPV1 activity, suggesting its role in blocking the calcium influx channel. Additionally, mYG-II-6 suppressed histamine-induced calcium increase in primary cultures of mouse dorsal root ganglia, indicating its potential antipruritic effect mediated by histamine. Interestingly, mYG-II-6 exhibited inhibitory effects on human MRGPRX2, a G protein-coupled receptor involved in IgE-independent mast cell degranulation. However, it did not inhibit mouse MrgprB2, the ortholog of human MRGPRX2. Molecular docking analysis revealed that mYG-II-6 selectively interacts with the binding pocket of MRGPRX2. Importantly, mYG-II-6 suppressed histamine-induced scratching behaviors in mice.

Conclusions: Our findings show that mYG-II-6 can alleviate histamine-induced itch sensation through dual mechanisms. This underscores its potential as a versatile treatment for various pruritic conditions.

Keywords: Histamine; Itch; MRGPRX2; Mast cell degranulation; TRPV1.

MeSH terms

  • Animals
  • Antipruritics / pharmacology
  • Antipruritics / therapeutic use
  • Calcium / metabolism
  • Cell Degranulation* / drug effects
  • Ganglia, Spinal / drug effects
  • Ganglia, Spinal / metabolism
  • HEK293 Cells
  • Histamine* / metabolism
  • Humans
  • Male
  • Mast Cells* / drug effects
  • Mast Cells* / immunology
  • Mice
  • Mice, Inbred C57BL
  • Molecular Docking Simulation*
  • Nerve Tissue Proteins / metabolism
  • Pruritus / drug therapy
  • Receptors, G-Protein-Coupled* / metabolism
  • Receptors, Neuropeptide / metabolism
  • Sphingosine / analogs & derivatives
  • Sphingosine / metabolism
  • Sphingosine / pharmacology
  • TRPV Cation Channels* / metabolism

Substances

  • TRPV Cation Channels
  • Histamine
  • Receptors, G-Protein-Coupled
  • Mrgprx2 protein, mouse
  • TRPV1 protein, mouse
  • Calcium
  • Antipruritics
  • Sphingosine
  • Nerve Tissue Proteins
  • Receptors, Neuropeptide
  • TRPV1 protein, human
  • MRGPRX2 protein, human